Treatment of patients with inhibitors: Cost issues

Haemophilia

Volumn 5, Issue 6, 1999, Pages 397-401

  Goudemand, J ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Coagulant factors; Cost; Inhibitor; rFVIIa

Indexed keywords

BLOOD CLOTTING INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; ALLOANTIBODY; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7A; PROTHROMBIN COMPLEX CONCENTRATES; RECOMBINANT PROTEIN;

BLEEDING; CONFERENCE PAPER; HEALTH CARE COST; HEMOPHILIA; HOME CARE; HOSPITALIZATION; HUMAN; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; ECONOMICS; HEMOPHILIA A; HEMOPHILIA B; IMMUNOLOGY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FACTOR VIIA; HEALTH CARE COSTS; HEMOPHILIA A; HEMOPHILIA B; HOME CARE SERVICES, HOSPITAL-BASED; HOSPITALIZATION; HUMANS; INFANT; ISOANTIBODIES; MIDDLE AGED; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 0033220609     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1999.00368.x     Document Type: Conference Paper

References (5)

1. Macik BG. Treatment of factor VIII inhibitors: products and strategies. Sem Thromb Haemost 1993; 19: 13-24.
2. Hedner U, Glazer S, Falch J. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. Trans Med Rev 1993; 7: 73-83.
3. Lipton RA. The economics of factor VIII inhibitor treatment. Semin Hematol 1994; 31 (Suppl. 2): 37-8.
4. Szucs TD, Öffner A, Schramm W. Socioeconomic impact of haemophilia care. Haemophilia 1996; 2: 211-7.
5. Miners AH, Sabin CA, Tolley KH, Lee CA. The changing patterns of factor VIII (FVIII) and factor IX (FIX) clotting factor usage in a comprehensive care centre between 1980 and 1994. Haemophilia 1998; 4: 4-9.